GILD
Stock Details
GILD is Gilead Sciences, Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 85.79$. Average daily volumn in 3 months 7.33M. Market cap 106.83B
Stock symbol : GILD. Exchange : NasdaqGS. Currency : USD Lastest price : 85.67$. Total volume : 7.02M. Market state POST Click reload if you want to check the lastest price on market!!!
Gilead Sciences, Inc. (GILD)
Last Price
85.67$Change
-0.38Volume
7.02M
| Previous Close | 86.05 |
| Open | 85.40 |
| Day Range | 85.29-86.03 |
| Bid | 85.48 x 900 |
| Ask | 85.54 x 800 |
| Volume | 7.02M |
| Average Volume | 7.33M |
| Market Cap | 106.83B |
| Beta | 0.41 |
| 52 Week Range | 57.17-89.74 |
| Trailing P/E | 23.54 |
| Foward P/E | 11.74 |
| Dividend (Yield %) | 3.49% |
| Ex-Dividend Date | 2023-03-14 |
Financial Details
Organization
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of li... ver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Market Cap:
106.83BRevenue:
27.28BTotal Assets:
63.17BTotal Cash:
5.41B
News about "Gilead Sciences, Inc."
Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2022 Earnings Call Transcript
Source from : YAHOO!Finance - 5 days ago
Q4 2022 Earnings Call February 2, 2023 Operator: Good afternoon. Thank you for attending today’s Fourth Quarter and Full Year 2022 Gilead Sciences Earnings Conference Call. My name is Henna, and I ...See details»
Gilead Sciences Reaches Analyst Target Price
Source from : Nasdaq - 1 days ago
In recent trading, shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $86.12, changing hands for $86.36/share. When a stock reaches the target ...See details»
Gilead Sciences Inc. (NASDAQ: GILD) Stock Forecast: Bearish Views Expect -3.06 Percent Drop In 2023
Source from : stocksregister - 1 days ago
The trading price of Gilead Sciences Inc. (NASDAQ:GILD) closed higher on Monday, February 06, closing at $86.36, 2.20% higher than its previous close. Traders who pay close attention to intraday price ...See details»
gilead sciences inc.
Source from : Fox Business - 5 days ago
Pfizer and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG are racing to produce the first antiviral pill that people could take at early signs of the ...See details»
Gilead Sciences Inc. stock rises Tuesday, still underperforms market
Source from : MarketWatch - 8 days ago
Shares of Gilead Sciences Inc. inched 0.71% higher to $83.94 Tuesday, on what proved to be an all-around great trading session for the stock market, with ...See details»
Gilead Sciences Inc. stock rises Wednesday, outperforms market
Source from : MarketWatch - 14 days ago
Shares of Gilead Sciences Inc. GILD inched 0.06% higher to $84.07 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA ...See details»
Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend
Source from : Barron's - 6 days ago
About Gilead Sciences Pfizer on Tuesday laid out guidance for the 2023 fiscal year well below Wall Street consensus figures, tempering investor expectations ahead of what it expects to be a steep drop ...See details»
Gilead Sciences Inc. Q4 Profit Increases, beats estimates
Source from : Business Insider - 6 days ago
Gilead Sciences Inc. (GILD) reported earnings for its fourth quarter that increased from the same period last year and beat the ...See details»
Gilead Sciences Inc. (GILD) Just Got Our Attention
Source from : newsheater - 2 years ago
Gilead Sciences Inc. (NASDAQ:GILD) went up by 0.13% from its latest closing price compared to the recent 1-year high of $89.74. The company’s stock price has collected 0.87% of gains in the last five ...See details»
Gilead Sciences Inc. (GILD) Volatility Hits 1.79%: What Good Investors Need To Be Aware Of
Source from : stocksregister - 6 days ago
Gilead Sciences Inc. (NASDAQ:GILD) price on Friday, February 03, rose 3.89% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $84.56. A look at the stock’s ...See details»
Gilead Sciences, Inc. (NASDAQ:GILD) Delivered A Weaker ROE Than Its Industry
Source from : Yahoo Finance - 15 days ago
By way of learning-by-doing, we'll look at ROE to gain a better understanding of Gilead Sciences, Inc. (NASDAQ:GILD). ROE or return on equity is a useful tool to assess how effectively a company ...See details»
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Could Be 40% Below Their Intrinsic Value Estimate
Source from : Yahoo News - 1 month ago
Today we will run through one way of estimating the intrinsic value of Gilead Sciences, Inc. (NASDAQ:GILD) by taking the expected future cash flows and discounting them to today's value. One way to ...See details»
Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates
Source from : MSN - 6 days ago
Gilead Sciences (GILD) came out with quarterly earnings of $1.67 ... Another stock from the same industry, Reata Pharmaceuticals, Inc. (RETA), has yet to report results for the quarter ended December ...See details»
Gilead Sciences Again Named to Dow Jones Sustainability World Index
Source from : Stockhouse - 1 month ago
FOSTER CITY, CA / ACCESSWIRE / January 5, 2023 / Gilead Sciences, Inc. (Nasdaq:GILD) announced the company has once again been recognized as one of the most sustainable pharmaceutical companies ...See details»